US 9301947
Ryanodine receptor inhibitors for treatment of T-cell mediated disorders
granted A61KA61K31/4025A61K31/4178
Quick answer
US patent 9301947 (Ryanodine receptor inhibitors for treatment of T-cell mediated disorders) held by The Regents of the University of California expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/4025, A61K31/4178, A61K31/422, A61K45/06